Karyopharm Therapeutics Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Karyopharm Therapeutics Inc. (KPTI) is 163.31M

According to Karyopharm Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 163.31M. This represents a change of -42.92% compared to the average of 286.10M of the last 4 quarters.

Karyopharm Therapeutics Inc. (KPTI) Historical Enterprise Value (quarterly & annually)

How has KPTI Enterprise Value performed in the past?

The mean historical Enterprise Value of Karyopharm Therapeutics Inc. over the last ten years is 501.83M. The current 163.31M Enterprise Value has changed -67.46% with respect to the historical average. Over the past ten years (40 quarters), KPTI's Enterprise Value was at its highest in in the June 2020 quarter at 1.41B. The Enterprise Value was at its lowest in in the March 2025 quarter at 179.60M.

Karyopharm Therapeutics Inc. (KPTI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Karyopharm Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Karyopharm Therapeutics Inc. (KPTI) Average Enterprise Value

How has KPTI Enterprise Value performed in the past?

The current Enterprise Value of Karyopharm Therapeutics Inc. (KPTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Karyopharm Therapeutics Inc. (KPTI) Enterprise Value vs. Peers

How is KPTI’s Enterprise Value compared to its peers?

Karyopharm Therapeutics Inc.’s Enterprise Value is greater than Senti Biosciences, Inc. (19.20M), greater than Barinthus Biotherapeutics plc (-18767734.00), greater than CEL-SCI Corporation (26.50M), less than X4 Pharmaceuticals, Inc. (221.71M), greater than Aligos Therapeutics, Inc. (3.16M), greater than FibroGen, Inc. (-32139522.00), greater than INmune Bio, Inc. (23.51M), greater than Mersana Therapeutics, Inc. (91.27M), greater than Medicus Pharma Ltd. Common Stock (7.15M), greater than Telomir Pharmaceuticals, Inc. Common Stock (64.40M),

Build a custom stock screener for Karyopharm Therapeutics Inc. (KPTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Karyopharm Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Karyopharm Therapeutics Inc. (KPTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Karyopharm Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.